Andrew Johnston
Andrew Johnston
Home
Posts
Publications
Light
Dark
Automatic
High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa.
Mondana H Ghias
,
Andrew D Johnston
,
Allison J Kutner
,
Robert G Micheletti
,
H Dean Hosgood
,
Steven R Cohen
May 2020
Cite
Journal Site
Type
Journal article
Publication
Journal of the American Academy of Dermatology
Cite
×